The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Research Report 2025
Synopsis
ERCP is a procedure that combines upper gastrointestinal (GI) endoscopy and x-rays to treat problems of the bile and pancreatic ducts.
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market is projected to reach US$ 2517.9 million in 2029, increasing from US$ 1366.7 million in 2022, with the CAGR of 9.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market research.
The Endoscopic Retrograde Cholangiopancreatography (ERCP) technique market was experiencing steady growth and advancements in medical technology. ERCP is a specialized endoscopic procedure used for diagnosing and treating disorders of the bile ducts, pancreatic duct, and gallbladder.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Olympus Corporation
CONMED Corporation
Fujifilm Holdings Corporation
HOYA Corporation
KARL STORZ SE & Co. KG
Ambu A/S
Boston Scientific Corporation
Johnson & Johnson
Medtronic, PLC
Cook Medical
B. Braun Melsungen AG
Hobbs Medical, Inc.
STERIS PLC
Merit Medical Systems, Inc.
TeleMed Systems, Inc.
Changzhou Health Microport Medical Device Co., LTD.
Medi-Globe GmbH
Taewoong Medical Co., Ltd.
Huger Medical Instrument Co., Ltd.
IntroMedic Co., Ltd.
SonoScape Medical Corporation
Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.
Ottomed
Kimberly-Clark Corporation
Shaili Endoscopy
Segment by Type
Endoscopes
Endotherapy Devices
Visualization Systems
Energy Devices
Others
Segment by Application
Hospitals
Ambulatory Surgery Centres & Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
ERCP is a procedure that combines upper gastrointestinal (GI) endoscopy and x-rays to treat problems of the bile and pancreatic ducts.
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market is projected to reach US$ 2517.9 million in 2029, increasing from US$ 1366.7 million in 2022, with the CAGR of 9.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market research.
The Endoscopic Retrograde Cholangiopancreatography (ERCP) technique market was experiencing steady growth and advancements in medical technology. ERCP is a specialized endoscopic procedure used for diagnosing and treating disorders of the bile ducts, pancreatic duct, and gallbladder.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Olympus Corporation
CONMED Corporation
Fujifilm Holdings Corporation
HOYA Corporation
KARL STORZ SE & Co. KG
Ambu A/S
Boston Scientific Corporation
Johnson & Johnson
Medtronic, PLC
Cook Medical
B. Braun Melsungen AG
Hobbs Medical, Inc.
STERIS PLC
Merit Medical Systems, Inc.
TeleMed Systems, Inc.
Changzhou Health Microport Medical Device Co., LTD.
Medi-Globe GmbH
Taewoong Medical Co., Ltd.
Huger Medical Instrument Co., Ltd.
IntroMedic Co., Ltd.
SonoScape Medical Corporation
Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.
Ottomed
Kimberly-Clark Corporation
Shaili Endoscopy
Segment by Type
Endoscopes
Endotherapy Devices
Visualization Systems
Energy Devices
Others
Segment by Application
Hospitals
Ambulatory Surgery Centres & Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Overview
1.1 Product Overview and Scope of Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique
1.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Segment by Type
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Value Comparison by Type (2023-2029)
1.2.2 Endoscopes
1.2.3 Endotherapy Devices
1.2.4 Visualization Systems
1.2.5 Energy Devices
1.2.6 Others
1.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Segment by Application
1.3.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centres & Clinics
1.3.4 Other
1.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size Estimates and Forecasts
1.4.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue 2018-2029
1.4.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales 2018-2029
1.4.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Competition by Manufacturers
2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales Market Share by Manufacturers (2018-2023)
2.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Average Price by Manufacturers (2018-2023)
2.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique, Product Type & Application
2.7 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Competitive Situation and Trends
2.7.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Players Market Share by Revenue
2.7.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Retrospective Market Scenario by Region
3.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Region: 2018-2029
3.2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Region: 2018-2023
3.2.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Region: 2024-2029
3.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Region: 2018-2029
3.3.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Region: 2018-2023
3.3.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Region: 2024-2029
3.4 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Facts & Figures by Country
3.4.1 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Country (2018-2029)
3.4.3 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Facts & Figures by Country
3.5.1 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Country (2018-2029)
3.5.3 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Facts & Figures by Country
3.6.1 Asia Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Country (2018-2029)
3.6.3 Asia Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Facts & Figures by Country
3.7.1 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Country (2018-2029)
3.7.3 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Facts & Figures by Country
3.8.1 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Country (2018-2029)
3.8.3 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Type (2018-2029)
4.1.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Type (2018-2023)
4.1.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Type (2024-2029)
4.1.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales Market Share by Type (2018-2029)
4.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Type (2018-2029)
4.2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Type (2018-2023)
4.2.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Type (2024-2029)
4.2.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue Market Share by Type (2018-2029)
4.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Price by Type (2018-2029)
5 Segment by Application
5.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Application (2018-2029)
5.1.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Application (2018-2023)
5.1.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales by Application (2024-2029)
5.1.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales Market Share by Application (2018-2029)
5.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Application (2018-2029)
5.2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Application (2018-2023)
5.2.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue by Application (2024-2029)
5.2.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue Market Share by Application (2018-2029)
5.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Olympus Corporation
6.1.1 Olympus Corporation Corporation Information
6.1.2 Olympus Corporation Description and Business Overview
6.1.3 Olympus Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Olympus Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.1.5 Olympus Corporation Recent Developments/Updates
6.2 CONMED Corporation
6.2.1 CONMED Corporation Corporation Information
6.2.2 CONMED Corporation Description and Business Overview
6.2.3 CONMED Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CONMED Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.2.5 CONMED Corporation Recent Developments/Updates
6.3 Fujifilm Holdings Corporation
6.3.1 Fujifilm Holdings Corporation Corporation Information
6.3.2 Fujifilm Holdings Corporation Description and Business Overview
6.3.3 Fujifilm Holdings Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fujifilm Holdings Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.3.5 Fujifilm Holdings Corporation Recent Developments/Updates
6.4 HOYA Corporation
6.4.1 HOYA Corporation Corporation Information
6.4.2 HOYA Corporation Description and Business Overview
6.4.3 HOYA Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HOYA Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.4.5 HOYA Corporation Recent Developments/Updates
6.5 KARL STORZ SE & Co. KG
6.5.1 KARL STORZ SE & Co. KG Corporation Information
6.5.2 KARL STORZ SE & Co. KG Description and Business Overview
6.5.3 KARL STORZ SE & Co. KG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.5.4 KARL STORZ SE & Co. KG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.5.5 KARL STORZ SE & Co. KG Recent Developments/Updates
6.6 Ambu A/S
6.6.1 Ambu A/S Corporation Information
6.6.2 Ambu A/S Description and Business Overview
6.6.3 Ambu A/S Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ambu A/S Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.6.5 Ambu A/S Recent Developments/Updates
6.7 Boston Scientific Corporation
6.6.1 Boston Scientific Corporation Corporation Information
6.6.2 Boston Scientific Corporation Description and Business Overview
6.6.3 Boston Scientific Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boston Scientific Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.7.5 Boston Scientific Corporation Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Medtronic, PLC
6.9.1 Medtronic, PLC Corporation Information
6.9.2 Medtronic, PLC Description and Business Overview
6.9.3 Medtronic, PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Medtronic, PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.9.5 Medtronic, PLC Recent Developments/Updates
6.10 Cook Medical
6.10.1 Cook Medical Corporation Information
6.10.2 Cook Medical Description and Business Overview
6.10.3 Cook Medical Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cook Medical Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.10.5 Cook Medical Recent Developments/Updates
6.11 B. Braun Melsungen AG
6.11.1 B. Braun Melsungen AG Corporation Information
6.11.2 B. Braun Melsungen AG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.11.3 B. Braun Melsungen AG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.11.4 B. Braun Melsungen AG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.11.5 B. Braun Melsungen AG Recent Developments/Updates
6.12 Hobbs Medical, Inc.
6.12.1 Hobbs Medical, Inc. Corporation Information
6.12.2 Hobbs Medical, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.12.3 Hobbs Medical, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hobbs Medical, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.12.5 Hobbs Medical, Inc. Recent Developments/Updates
6.13 STERIS PLC
6.13.1 STERIS PLC Corporation Information
6.13.2 STERIS PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.13.3 STERIS PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.13.4 STERIS PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.13.5 STERIS PLC Recent Developments/Updates
6.14 Merit Medical Systems, Inc.
6.14.1 Merit Medical Systems, Inc. Corporation Information
6.14.2 Merit Medical Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.14.3 Merit Medical Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Merit Medical Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.14.5 Merit Medical Systems, Inc. Recent Developments/Updates
6.15 TeleMed Systems, Inc.
6.15.1 TeleMed Systems, Inc. Corporation Information
6.15.2 TeleMed Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.15.3 TeleMed Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.15.4 TeleMed Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.15.5 TeleMed Systems, Inc. Recent Developments/Updates
6.16 Changzhou Health Microport Medical Device Co., LTD.
6.16.1 Changzhou Health Microport Medical Device Co., LTD. Corporation Information
6.16.2 Changzhou Health Microport Medical Device Co., LTD. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.16.3 Changzhou Health Microport Medical Device Co., LTD. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Changzhou Health Microport Medical Device Co., LTD. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.16.5 Changzhou Health Microport Medical Device Co., LTD. Recent Developments/Updates
6.17 Medi-Globe GmbH
6.17.1 Medi-Globe GmbH Corporation Information
6.17.2 Medi-Globe GmbH Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.17.3 Medi-Globe GmbH Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Medi-Globe GmbH Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.17.5 Medi-Globe GmbH Recent Developments/Updates
6.18 Taewoong Medical Co., Ltd.
6.18.1 Taewoong Medical Co., Ltd. Corporation Information
6.18.2 Taewoong Medical Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.18.3 Taewoong Medical Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Taewoong Medical Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.18.5 Taewoong Medical Co., Ltd. Recent Developments/Updates
6.19 Huger Medical Instrument Co., Ltd.
6.19.1 Huger Medical Instrument Co., Ltd. Corporation Information
6.19.2 Huger Medical Instrument Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.19.3 Huger Medical Instrument Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Huger Medical Instrument Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.19.5 Huger Medical Instrument Co., Ltd. Recent Developments/Updates
6.20 IntroMedic Co., Ltd.
6.20.1 IntroMedic Co., Ltd. Corporation Information
6.20.2 IntroMedic Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.20.3 IntroMedic Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.20.4 IntroMedic Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.20.5 IntroMedic Co., Ltd. Recent Developments/Updates
6.21 SonoScape Medical Corporation
6.21.1 SonoScape Medical Corporation Corporation Information
6.21.2 SonoScape Medical Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.21.3 SonoScape Medical Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.21.4 SonoScape Medical Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.21.5 SonoScape Medical Corporation Recent Developments/Updates
6.22 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.
6.22.1 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Corporation Information
6.22.2 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.22.3 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.22.5 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Recent Developments/Updates
6.23 Ottomed
6.23.1 Ottomed Corporation Information
6.23.2 Ottomed Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.23.3 Ottomed Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Ottomed Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.23.5 Ottomed Recent Developments/Updates
6.24 Kimberly-Clark Corporation
6.24.1 Kimberly-Clark Corporation Corporation Information
6.24.2 Kimberly-Clark Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.24.3 Kimberly-Clark Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Kimberly-Clark Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.24.5 Kimberly-Clark Corporation Recent Developments/Updates
6.25 Shaili Endoscopy
6.25.1 Shaili Endoscopy Corporation Information
6.25.2 Shaili Endoscopy Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Description and Business Overview
6.25.3 Shaili Endoscopy Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Shaili Endoscopy Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Portfolio
6.25.5 Shaili Endoscopy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Industry Chain Analysis
7.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Production Mode & Process
7.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales and Marketing
7.4.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Sales Channels
7.4.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Distributors
7.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Customers
8 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Dynamics
8.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Industry Trends
8.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Drivers
8.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Challenges
8.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
